Skip to the content
halfrx
← LillyDirect

orforglipron through LillyDirect

$299
a month all-in, once titrated
✓ verified 2026-09-13

Last updated 2026-09-13 — the price on this page. Read and dated by Alex Seot.

Can you get orforglipron through LillyDirect, and what does it cost?

LillyDirect supplies orforglipron as the branded, FDA-approved product. halfrx records $299 a month all-in once titrated, read from its own published page on 2026-09-13. That is the maintenance figure rather than an introductory rate, because the starting dose is not the dose anyone stays on. Nothing sits on LillyDirect's public record here: no FTC action, no state action, no failing BBB grade and no matched FDA warning letter.

What LillyDirect gets right, and what it does not

Each line is read from a cited source rather than from a reviewer's impression, and these are LillyDirect's own — nothing here is shared with the other sellers of this molecule.

  • +You buy from Eli Lilly itself. No telehealth membership, no cancellation policy to fight, no compounding pharmacy in the chain.
  • +Zepbound vials from $299/mo at the starter dose against a $1,086 list price — the largest manufacturer discount in the category.
  • +Foundayo (orforglipron) from $149 a month, the lowest self-pay price for a branded GLP-1 on this site, and a daily pill.
  • +Tirzepatide delivers the strongest average weight loss of any approved molecule.
  • −Lilly molecules only. If tirzepatide does not suit you, this channel has no semaglutide alternative.
  • −No clinical program, coaching or side-effect management — it is a pharmacy, not a weight service.
  • −Self-pay pricing is dose-scaled, so the $299 and $149 headlines are starter doses, not maintenance.
  • −Both products price maintenance doses on a 45-day refill condition, and Lilly counts a month as 28 days — so the advertised figure is a floor that assumes you never lapse.

What orforglipron does, on the trial evidence

ATTAIN-1, Trial 1 on the label, 72 weeks: 11.1% mean weight loss at 17.2 mg against 2.1% on placebo, intention-to-treat. It is the trial behind Foundayo, the approved product built on this molecule.

FDA status of the approved product: FDA approved for chronic weight management, since 2026-04-01.

List price of the approved product is $649 a month, against $299 here — a gap of $350 a month, or $4,200 a year, which is the whole reason this route exists.

Which products orforglipron is sold as, and what each costs direct

ProductDirect priceMaintenance doseChecked
Foundayo$2995.5 mg, 9 mg, 14.5 mg or 17.2 mg daily2026-09-12

What you are actually buying each month

Foundayo

One tablet a day. The label reaches the maintenance dose in week 9, so the first 8 weeks are on a lower starting dose. An advertised starting price buys that dose, not the one you stay on, which is why the price above is the maintenance one.

WeeksDoseNote
Days 1–300.8 mg dailyInitiation.
Days 31–602.5 mg daily—
Days 61–905.5 mg dailyThe first dose the label does not require you to leave: escalation is mandatory up to here, and every step above is optional, on response and tolerability.
Day 91 and on9 mg → 14.5 mg → 17.2 mgOne step at a time, at least 30 days apart, on response and tolerability.

Maintenance: 5.5 mg, 9 mg, 14.5 mg or 17.2 mg daily. FDA prescribing information for Foundayo (orforglipron)

Why LillyDirect rather than the cheapest route

Computed for this seller against every other verified route to the same molecule, so it is a different answer on every one of these pages.

What only this route gives
The only verified route to this molecule on this site.
What the money buys besides the drug
LillyDirect sells the medication only, filled against a prescription written elsewhere. There is no program around the drug to pay for.

Everything on LillyDirect

This page exists only where LillyDirect actually supplies orforglipron in the same form the medication is sold in — sharing a molecule is not the same as selling the product. Every figure carries its source and the date it was read.

Something on this page wrong? Tell us

Please leave out anything about your own health. How a report is handled: privacy.